🟢 Cue Biopharma is trading 11.4% up today with no clear catalyst identified

Cue Biopharma is trading 11.4% up at $28.43, with no clear company-specific catalyst identified for September 1, 2026.

• The move follows an 8.46% decline on August 31, 2026.
• No company-specific announcement, FDA event, analyst action, or other direct catalyst was identified; investor-relations releases show no newer announcement.
• With the broader market and biotech sector lower, the gain appears idiosyncratic or trading-driven. Confidence remains low pending a potential delayed disclosure.